Skip to main content
. 2022 Mar 30;12:838870. doi: 10.3389/fonc.2022.838870

Figure 3.

Figure 3

Kaplan–Meier survival curves. (A, B) Kaplan–Meier survival curves of different starting doses on PFS and OS [(A) PFS of patients with different start doses, p < 0.001; (B) OS of patients with different starting doses; p = 0.005]; (C, D) Kaplan–Meier survival curves of different final doses on PFS and OS [(C) PFS of patients with different final doses, p = 0.045; (D) OS of patients with different final doses; p = 0.003].